Versant Capital Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.4K | Sell |
200
-497
| -71% | -$8.45K | ﹤0.01% | 2282 |
|
2025
Q1 | $13.6K | Buy |
697
+5
| +0.7% | +$98 | ﹤0.01% | 1558 |
|
2024
Q4 | $17.2K | Buy |
692
+195
| +39% | +$4.84K | ﹤0.01% | 1110 |
|
2024
Q3 | $12.2K | Buy |
497
+433
| +677% | +$10.6K | ﹤0.01% | 991 |
|
2024
Q2 | $1.5K | Buy |
+64
| New | +$1.5K | ﹤0.01% | 1581 |
|
2023
Q4 | – | Sell |
-7
| Closed | -$168 | – | 1925 |
|
2023
Q3 | $168 | Sell |
7
-98
| -93% | -$2.35K | ﹤0.01% | 1892 |
|
2023
Q2 | $3.35K | Buy |
+105
| New | +$3.35K | ﹤0.01% | 1177 |
|